Rising Incidence of Meniscal Injuries Driving U.S. Meniscus Treatment Market at an Estimated CAGR of 5% During 2025-30

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The U.S. Meniscus Treatment Market size was valued at around USD245.87 million in 2024 and is projected to reach USD329.49 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 5% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The U.S. Meniscus Treatment Market growth is driven by several factors, including the high incidence of meniscus injuries due to sports activities & rising aging population in the country, the government support through substantial investments along with the private funding by the universities and research institutes, the ongoing research and development studies for identifying better treatment procedures, the adoption of advanced procedures such as minimally invasive and robotic assisted surgeries, etc.

One of the prime factors for the market growth is a surge in the US geriatric population, which is highly vulnerable to meniscus tears and injuries due to other associated factors such as osteoarthritis, low elasticity & collagen fibers, and fatigued muscles in their bodies. These factors are creating a high demand for meniscus treatment, thus increasing market growth.

Additionally, the country is witnessing continuous research and development in the medical device industry backed by government support, including the innovative meniscus treatment procedures, which will be cost-effective, long-lasting, and less painful. These efforts are creating ample growth opportunities in this market. Moreover, the market is gaining traction due to the incorporation of the latest innovative techniques, including robotic-assisted surgeries and minimally invasive procedures in this market. These techniques have improved the treatment procedures, enabled with high automation and the incorporation of Artificial Intelligence. However, the high treatment costs and a shortage of trained professionals to operate the advanced medical devices for the meniscus treatment in the country are hindering the market growth, further states the research report, “U.S. Meniscus Treatment Market Analysis, 2025.”

U.S. Meniscus Treatment Market Segmentation Analysis

Meniscus Repair Devices Hold the Largest Market Share

Based on the product type, the market is further bifurcated into Meniscectomy Devices, Meniscus Repair Devices, Meniscus Replacement (Allograft/Implant), Meniscus Scaffold, and Others (e.g., Sutures, Fixation Devices). Among these, the meniscus repair devices are dominating the national industry with a market share of more than 40%. The market growth is driven by the patients' preference to repair the damaged meniscus instead of meniscectomy, in which the damaged part of the meniscus is surgically removed.

Repair treatment is more beneficial, as it is related to a lower risk of post-surgery osteoarthritis as compared to other types of treatment. Hundreds of thousands of meniscus repair surgeries are performed annually in the U.S., demanding a significant number of meniscus repair devices and generating the highest revenue over other meniscal surgeries, showing its dominance in the country.

Additionally, many health insurance policies provide an adequate amount of financial support for repairing treatments, including meniscus repair surgeries, which is creating a huge demand for meniscus repair devices in the country. It has attracted patients to opt for repair surgeries rather than removal surgeries, such as Meniscectomy. These factors are contributing to the dominance of these devices in the U.S. Meniscus Treatment Market.

Hospitals Generating Maximum Demand for U.S. Meniscus Treatment Industry

Hospitals hold the largest market share of about 35%. The well-established infrastructure of hospitals allows a large space setting to install the advanced medical devices and machinery for performing surgical procedures, including meniscus treatment. The treatment cannot be done without advanced devices and surgeries; thus, hospitals are the core infrastructure for these kinds of treatments. Additionally, hospitals provide highly skilled and trained professionals to perform these kinds of surgeries, which are not provided efficiently by other kinds of end users, such as small medical centers, academic institutes, and ambulatory surgical centers. Many hospitals are proactively using these procedures in the United States and increasing the market’s growth.

Moreover, hospitals can deal with a large volume of patients simultaneously and save time and money by providing better patient outcomes. Hundreds of thousands of meniscus surgeries have been performed in the U.S hospitals alone, contributing to the dominance of hospitals. These factors are augmenting the revenue growth of hospitals in the US Meniscus Treatment Industry.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Smith+Nephew plc, Arthrex, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), ConMed Corporation, Medtronic plc, RTI Surgical Holdings, Inc., Bioventus Inc., and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the country?
4. How has the industry been evolving in terms of geography & solution adoption?
5. How has the competition been shaping up across the country?
6. How have buying behavior, customer inclination, and expectations from solution providers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?